Markers for Identifying and Targeting Glioblastoma Cells during Surgery

被引:13
|
作者
Schipmann, Stephanie [1 ]
Schwake, Michael [1 ]
Molina, Eric Suero [1 ]
Stummer, Walter [2 ]
机构
[1] Univ Hosp Munster, Dept Neurosurg, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany
[2] UK Munster, NCH, Munster, Germany
关键词
glioma; interoperative MRI; 5-ALA; fluorescein; indocyanine green; HIGH-GRADE GLIOMAS; FLUORESCENCE-GUIDED RESECTION; GROSS TOTAL RESECTION; INDOCYANINE GREEN VIDEOANGIOGRAPHY; SURGICAL MICROSCOPE FILTER; PROSPECTIVE PHASE-II; BRAIN-TUMOR SURGERY; 5-AMINOLEVULINIC ACID; VOLUMETRIC-ANALYSIS; MALIGNANT GLIOMAS;
D O I
10.1055/s-0039-1692976
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glioblastoma is a highly malignant tumor with a poor prognosis. A factor influencing survival that can be affected by the surgeon is the extent of resection (EOR). Due to the infiltrative nature of the tumor, delineation of tumor from normal brain parenchyma is often challenging. To improve EOR and facilitate tumor visualization, several techniques have been developed over the last few years. This literature review presents an overview of current intraoperative strategies for identifying and targeting glioma cells and discusses the benefits and limitations of each technique. Along with conventional techniques such as neuronavigation and ultrasound, fluorescence-guided surgery with different fluorescent agents such as 5-aminolevulinc acid and fluorescein have been widely used. Recently, newer techniques have emerged and are being translated into the operating room, promising delineation of glioblastoma tissue using targeted approaches or identification on a microscopic level, for instance using Raman spectroscopy or confocal microscopy.
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [31] Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI
    Anwar, Mekhail
    Molinaro, Annette M.
    Morin, Olivier
    Chang, Susan M.
    Haas-Kogan, Daphne A.
    Nelson, Sarah J.
    Lupo, Janine M.
    RADIATION RESEARCH, 2017, 188 (03) : 303 - 313
  • [32] Targeting the Synthetic Vulnerability of PTEN-Deficient Glioblastoma Cells with MCL1 Inhibitors
    Chen, Chao
    Zhu, Sichao
    Zhang, Xia
    Zhou, Tingting
    Gu, Jing
    Xu, Yurong
    Wan, Quan
    Qi, Xiao
    Chai, Yezi
    Liu, Xiaorong
    Chen, Lukui
    Yan, Jie
    Hua, Yunfen
    Lin, Fan
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2001 - 2011
  • [33] Astragalus Polysaccharides Affect Glioblastoma Cells Through Targeting miR-34a-5p
    Liu, Hongjun
    Qi, Lingjun
    Tang, Xiaoping
    Tan, Shasha
    Gou, Zhangyang
    Qi, Jian
    Lu, Xingyu
    Li, Dong
    Chen, Chunbao
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (07) : 1454 - 1459
  • [34] Nanoparticle-Programmed Self-Destructive Neural Stem Cells for Glioblastoma Targeting and Therapy
    Cheng, Yu
    Morshed, Ramin
    Cheng, Shih-Hsun
    Tobias, Alex
    Auffinger, Brenda
    Wainwright, Derek A.
    Zhang, Lingjiao
    Yunis, Catherine
    Han, Yu
    Chen, Chin-Tu
    Lo, Leu-Wei
    Aboody, Karen S.
    Ahmed, Atique U.
    Lesniak, Maciej S.
    SMALL, 2013, 9 (24) : 4123 - 4129
  • [35] MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A
    Yue, Xiao
    Wang, Peiguo
    Xu, Jun
    Zhu, Yufang
    Sun, Guan
    Pang, Qi
    Tao, Rongjie
    ONCOLOGY REPORTS, 2012, 27 (04) : 1200 - 1206
  • [36] Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
    Affinito, Alessandra
    Quintavalle, Cristina
    Esposito, Carla Lucia
    Roscigno, Giuseppina
    Giordano, Catello
    Nuzzo, Silvia
    Ricci-Vitiani, Lucia
    Scognamiglio, Iolanda
    Minic, Zoran
    Pallini, Roberto
    Berezovski, Maxim, V
    de Francisis, Vittorio
    Condorelli, Gerolama
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 20 : 176 - 185
  • [37] Expression of diagnostic neuronal markers and outcome in glioblastoma
    Donev, K.
    Scheithauer, B. W.
    Rodriguez, F. J.
    Jenkins, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (05) : 411 - 421
  • [38] Evaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers
    Naryzhny, Stanislav
    Ronzhina, Natalia
    Zorina, Elena
    Kabachenko, Fedor
    Zavialova, Maria
    Zgoda, Viktor
    Klopov, Nikolai
    Legina, Olga
    Pantina, Rimma
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [39] Resection and survival data from a clinical trial of glioblastoma multiforme-specificIRDye800-BBNfluorescence-guided surgery
    He, Kunshan
    Chi, Chongwei
    Li, Deling
    Zhang, Jingjing
    Niu, Gang
    Lv, Fangqiao
    Wang, Junmei
    Che, Wenqiang
    Zhang, Liwei
    Ji, Nan
    Zhu, Zhaohui
    Tian, Jie
    Chen, Xiaoyuan
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (01)
  • [40] Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?
    Seystahl, Katharina
    Weller, Michael
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (05) : 605 - 617